Repetitive transcranial magnetic stimulation combined with antidepressants for first episode of major depressive disorder.
CONCLUSION: According to a limited evidence, the high-frequency repetitive transcranial magnetic stimulation (HF-rTMS) could accelerate the antidepressant effect of SSRIs in young patients with a first-episode major depressive disorder. However, the acceptability and tolerability of HF-rTMS in the treatment of such patients is no better than an antidepressant alone. However, further well-defined and large sample-size studies of HF-rTMS combined with antidepressant in MDD should be carried out to warrant these results.
PMID: 32091338 [PubMed - as supplied by publisher]
Source: Current Neuropharmacology - Category: Drugs & Pharmacology Authors: Maneeton B, Maneeton N, Woottiluk P, Likhitsathian S Tags: Curr Neuropharmacol Source Type: research
More News: Brain | Celexa | Citalopram | Databases & Libraries | Depression | Drugs & Pharmacology | Neurology | Paroxetine | Paxil | Study